AMY ABERNETHY, M.D., PH.D.

Former Principal Deputy Commissioner

FDA

Noubar Afeyan, Ph.D.

Founder & CEO

Flagship Pioneering

Houman Ashrafian, D.Phil.

EVP of R&D

Sanofi

Jamil Beg

Partner

SV Health Investors

Kate Bingham

Managing Partner

SV Health Investors

MELISSA BONNER, PH.D.

Chief Scientific Officer

Nvelop Therapeutics

LUCIANA BORIO, M.D.

Venture Partner

Arch Venture Partners

SHELLEY CHU, M.D., PH.D.

Partner, Head of Biotech

Lightspeed Ventures

Aaron Esser-Kahn, Ph.D.

Professor of Molecular Engineering

University of Chicago

TODD FOLEY

Managing Director

MPM BioImpact

DAVID GOLDSTEIN, PH.D.

Co-founder & CEO

Actio Biosciences

ANIKA GUPTA, PH.D.

Principal

GV

COLIN HILL

CEO

Aitia

NAJAT KHAN, PH.D.

Chief Data Science Officer

Johnson & Johnson

SOPHIE KORNOWSKI, PHARM.D.

CEO

Boston Pharmaceuticals

JOHN LEPORE, M.D.

CEO

ProFound Therapeutics

MATHAI MAMMEN, M.D., PH.D.

Chairman & CEO

FogPharma

GREGORY NEWBY, PH.D.

Assistant Professor

Johns Hopkins University

ANTOINE PAPIERNIK

Chairman & Managing Partner

Sofinnova Partners

KUSH PARMAR, M.D., PH.D.

Managing Partner

5AM Ventures

CARY PFEFFER, M.D.

Partner

Third Rock Ventures

Andrew Plump, M.D., Ph.D.

President of R&D

Takeda Pharmaceutical Co. Ltd.

Daniel Reich, M.D., Ph.D.

Chief, Translational Neuroradiology Section, NINDS, NIH Attending Neuroradiologist

NIH Clinical Center

James Sabry, M.D., Ph.D.

EVP and CBO

BioMarin Pharmaceutical Inc.

Otello Stampacchia, Ph.D.

Founder and Managing Director

Omega Funds

PAUL PETER TAK, M.D., PH.D.

President and CEO

Candel Therapeutics

Marc Tessier-Lavigne, Ph.D.

Professor

Stanford University

Jérôme Van Biervliet, Ph.D.

Managing Director

VIB

Jan van de Winkel, Ph.D.

President and CEO

Genmab A/S

DOUGLAS WILLIAMS, PH.D.

Head of R&D

Sana Biotechnology